PAVmed Inc buy Marianka
Start price
21.03.22
/
70%
€1.35
Target price
21.03.23
€8.00
Performance (%)
-14.92%
End price
02.04.22
€1.15
Summary
This prediction ended on 02.04.22 with a price of €1.15. The price of PAVmed Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -14.92%. Marianka has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| PAVmed Inc | - | - | - |
| iShares Core DAX® | 2.594% | -1.158% | 14.782% |
| iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% |
| iShares Nikkei 225® | 0.687% | -8.354% | 18.454% |
| iShares S&P 500 | 2.209% | -0.942% | 31.361% |
According to Marianka what are the pros and cons of PAVmed Inc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Standard Investments for future growth
Capable Management
Good culture
Leading role in innovation
Some uniques
Growths faster than the competition
Sustainability is important
Small cyclical dependencies
Cons
Revenue decline/stagnation expected
Very low/no dividend yield expected
Junk rating
very negative Cash Flow expected
High risks in the balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Dependend from some customers or products
high free float
Higher risks for its business
Below average Marketposition
Little known brand
Business model of the past or high risk